Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$115.96 +1.7%	$132.16	$112.47 ▼ $155.35	$33.06B	1.19	1.78 million shs	1.95 million shs
DHR Danaher	$205.23 +2.4%	$212.24	$196.80 ▼ $281.70	$146.68B	0.82	3.19 million shs	2.97 million shs
TMO Thermo Fisher Scientific	$489.25 +1.3%	$536.85	$473.50 ▼ $627.88	$184.57B	0.79	1.63 million shs	2.07 million shs
WAT Waters	$362.21 +1.7%	$384.62	$279.24 ▼ $423.56	$21.52B	1	457,001 shs	526,377 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	-2.84%	-5.55%	-11.08%	-15.39%	-21.88%
DHR Danaher	-2.40%	-5.78%	-3.68%	-12.83%	-19.25%
TMO Thermo Fisher Scientific	-3.12%	-6.09%	-8.79%	-7.25%	-16.48%
WAT Waters	-3.56%	-3.47%	-5.78%	-4.19%	+3.17%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
A Agilent Technologies	4.3904 of 5 stars	3.2	3.0	1.7	3.6	3.6	0.8	1.3
DHR Danaher	4.9587 of 5 stars	4.4	4.0	1.7	4.2	3.6	3.3	1.3
TMO Thermo Fisher Scientific	4.9155 of 5 stars	4.4	3.0	1.7	4.1	4.2	2.5	1.3
WAT Waters	4.4019 of 5 stars	3.3	5.0	0.0	3.5	2.5	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.46	Hold	$150.83	30.07% Upside
DHR Danaher	2.81	Moderate Buy	$278.24	35.57% Upside
TMO Thermo Fisher Scientific	2.82	Moderate Buy	$653.23	33.52% Upside
WAT Waters	2.61	Moderate Buy	$401.31	10.80% Upside

Current Analyst Ratings Breakdown

Latest A, TMO, DHR, and WAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/31/2025	WAT Waters	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$460.00
3/26/2025	WAT Waters	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
3/26/2025	WAT Waters	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$396.00 ➝ $407.00
3/21/2025	DHR Danaher	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$260.00
3/14/2025	DHR Danaher	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$260.00
3/6/2025	WAT Waters	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$380.00 ➝ $390.00
3/4/2025	TMO Thermo Fisher Scientific	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$650.00 ➝ $570.00
2/27/2025	A Agilent Technologies	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$161.00 ➝ $159.00
2/13/2025	WAT Waters	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$415.00 ➝ $420.00
2/13/2025	WAT Waters	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$405.00 ➝ $410.00
2/13/2025	WAT Waters	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$430.00 ➝ $450.00

(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.51B	5.08	$6.19 per share	18.72	$21.14 per share	5.49
DHR Danaher	$23.88B	6.14	$10.78 per share	19.03	$68.60 per share	2.99
TMO Thermo Fisher Scientific	$42.88B	4.30	$27.32 per share	17.91	$129.54 per share	3.78
WAT Waters	$2.96B	7.27	$14.38 per share	25.18	$30.80 per share	11.76

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.29B	$4.35	26.66	19.07	3.28	19.27%	25.56%	13.47%	5/27/2025 (Estimated)
DHR Danaher	$3.90B	$5.28	38.87	23.95	2.66	16.33%	10.82%	6.90%	4/22/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$16.53	29.60	19.14	2.99	14.78%	17.51%	8.52%	4/23/2025 (Estimated)
WAT Waters	$637.83M	$10.71	33.82	25.71	3.79	21.56%	46.31%	15.67%	5/6/2025 (Estimated)

Latest A, TMO, DHR, and WAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/23/2025	N/A	TMO Thermo Fisher Scientific	$5.11	N/A	N/A	N/A	$10.23 billion	N/A
4/22/2025	N/A	DHR Danaher	$1.62	N/A	N/A	N/A	$5.58 billion	N/A
2/26/2025	Q1 2025	A Agilent Technologies	$1.27	$1.31	+$0.04	$1.11	$1.67 billion	$1.68 billion
2/12/2025	Q4 2024	WAT Waters	$4.02	$4.10	+$0.08	$3.88	$856.87 million	N/A
1/30/2025	Q4 2024	TMO Thermo Fisher Scientific	$5.94	$6.10	+$0.16	$4.78	$11.29 billion	N/A
1/29/2025	Q4 24	DHR Danaher	$2.14	$2.14	N/A	$1.49	$6.38 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$0.99	0.85%	+6.47%	22.76%	N/A
DHR Danaher	$1.28	0.62%	+8.74%	24.24%	N/A
TMO Thermo Fisher Scientific	$1.72	0.35%	+14.47%	10.41%	N/A
WAT Waters	N/A	N/A	N/A	N/A	N/A

Latest A, TMO, DHR, and WAT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/20/2025	DHR Danaher	quarterly	$0.32	0.62%	3/28/2025	3/28/2025	4/25/2025
2/19/2025	A Agilent Technologies	quarterly	$0.2480	0.72%	4/1/2025	4/1/2025	4/23/2025
2/19/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.32%	3/14/2025	3/14/2025	4/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.56	2.20	1.66
DHR Danaher	0.31	1.40	1.05
TMO Thermo Fisher Scientific	0.59	1.66	1.29
WAT Waters	1.14	0.94	0.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
DHR Danaher	79.05%
TMO Thermo Fisher Scientific	89.23%
WAT Waters	94.01%

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
DHR Danaher	11.10%
TMO Thermo Fisher Scientific	0.34%
WAT Waters	0.82%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	17,900	285.10 million	N/A	Optionable
DHR Danaher	81,000	714.71 million	642.10 million	Optionable
TMO Thermo Fisher Scientific	130,000	377.26 million	381.20 million	Optionable
WAT Waters	8,200	59.41 million	58.89 million	Optionable

A, TMO, DHR, and WAT Headlines

Recent News About These Companies

Small dog plucked out of 'ruff waters' of New York's East River

April 2 at 8:57 PM | msn.com

Moment Missing Dog Found in 'Freezing Waters' After 2 Day Search

April 2 at 8:57 PM | msn.com

'Very own co-president' Musk could launch his stablecoin, Maxine Waters claims

April 2 at 8:57 PM | msn.com

NYPD Harbor heroes recall saving pup from frigid East River waters with moments to spare: ‘It seemed relived’

April 2 at 8:57 PM | msn.com

Lawmaker alleges Trump wants to replace US dollar with his stablecoin

April 2 at 5:18 PM | cointelegraph.com

Ecopetrol Hunts for Offshore Gas Reserves in Caribbean Waters

April 2 at 3:22 PM | financialpost.com

Analysts Issue Forecasts for Waters' Q1 Earnings (NYSE:WAT)

April 2 at 6:28 AM | marketbeat.com

Allstate Corp Acquires New Shares in Waters Co. (NYSE:WAT)

April 2 at 4:48 AM | marketbeat.com

Waters Co. (NYSE:WAT) Shares Acquired by Korea Investment CORP

April 2 at 4:06 AM | marketbeat.com

Waters (NYSE:WAT) Stock Rating Upgraded by KeyCorp

April 2 at 2:07 AM | americanbankingnews.com

3-year-old’s body recovered 10 days after boat capsized in Florida waters: report

April 1 at 1:37 PM | msn.com

Fans watch play during a match of the TMRW Golf League…

TGL indoor golf hitting a younger audience and already contemplating expansion

April 1 at 8:45 AM | marketbeat.com

China Sends High-Tech 'Spy Ship' to Australian Waters

April 1 at 8:37 AM | msn.com

Waters (NYSE:WAT) Upgraded at KeyCorp

April 1 at 8:04 AM | marketbeat.com

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

April 1 at 8:00 AM | prnewswire.com

Waters Co. (NYSE:WAT) Shares Purchased by Alliancebernstein L.P.

April 1 at 6:38 AM | marketbeat.com

China’s Tan Suo Yi Hao Sparks Espionage Concerns in Australian Waters

April 1 at 12:21 AM | msn.com

Positive Report for Waters (WAT) from KeyBanc

March 31 at 7:20 PM | markets.businessinsider.com

John Waters’ Upcoming Show: “The Naked Truth”

March 31 at 7:20 PM | localsyr.com

This Is the No. 1 Boating Destination in the Caribbean—and It Has Turquoise Waters and World-famous Cays

March 31 at 7:20 PM | msn.com

Waters upgraded to Overweight from Sector Weight at KeyBanc

March 31 at 7:20 PM | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
3 Defense Stocks Set to Benefit From Increased Military Spending
By Chris Markoch | March 20, 2025
View 3 Defense Stocks Set to Benefit From Increased Military Spending
Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
By Jeffrey Neal Johnson | March 10, 2025
View Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality

A, TMO, DHR, and WAT Company Descriptions

Agilent Technologies NYSE:A

$115.96 +1.91 (+1.67%)

Closing price 03:58 PM Eastern

Extended Trading

$112.92 -3.04 (-2.62%)

As of 07:58 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Danaher NYSE:DHR

$205.23 +4.84 (+2.42%)

Closing price 03:58 PM Eastern

Extended Trading

$199.30 -5.93 (-2.89%)

As of 08:00 PM Eastern

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Thermo Fisher Scientific NYSE:TMO

$489.25 +6.28 (+1.30%)

Closing price 03:58 PM Eastern

Extended Trading

$475.26 -13.99 (-2.86%)

As of 07:59 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Waters NYSE:WAT

$362.21 +6.21 (+1.74%)

Closing price 03:58 PM Eastern

Extended Trading

$352.35 -9.86 (-2.72%)

As of 06:21 PM Eastern

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time